Your browser doesn't support javascript.
loading
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies.
Davis, James A; Granger, Katelynn; Roubal, Kiera; Smith, Deidra; Gaffney, Kelly J; McGann, Mary; Cendagorta, Alyssa; Thurlapati, Aswani; Herbst, Amanda; Hendrickson, Lindsey; Hashmi, Hamza; Hess, Brian T.
Afiliação
  • Davis JA; Department of Pharmacy, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Granger K; Department of Pharmacy, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Roubal K; Department of Pharmacy, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Smith D; Department of Pharmacy, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Gaffney KJ; Department of Pharmacy, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • McGann M; Department of Pharmacy, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Cendagorta A; Department of Pharmacy, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Thurlapati A; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Herbst A; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Hendrickson L; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Hashmi H; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
  • Hess BT; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC.
Blood ; 141(2): 200-203, 2023 01 12.
Article em En | MEDLINE | ID: mdl-36332185

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article